QT dispersion for detection of cardiac allograft vasculopathy in heart transplant patients

被引：0
|
作者：
Kashem, A.
Panse, S.
Cross, R. C.
Santamore, W. P.
Bove, A. A.
机构：
[1] Temple Univ, Cardiol Sect, Philadelphia, PA 19122 USA
[2] Abington Mem Hosp, Philadelphia, PA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2007年 / 26卷 / 02期
关键词：
D O I：
10.1016/j.healun.2006.11.034
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
20
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [41] Implementing Coronary CT for Routine Annual Surveillance of Cardiac Allograft Vasculopathy in Heart Transplant Patients
    Roest, S.
    Nous, F. M.
    Attrach, M.
    Caliskan, K.
    Brugts, J. J.
    Nieman, K.
    Hirsch, A.
    Constantinescu, A. A.
    Manintveld, O. C.
    Budde, R. P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S206 - S206
  • [42] Diagnosis of cardiac allograft vasculopathy in heart transplant patients using a pixelated stress perfusion analysis
    Hanna, Alexander Benjamin
    BMJ OPEN QUALITY, 2019, 8 (03)
  • [43] When to list for re-do heart transplant in patients with severe cardiac allograft vasculopathy
    Patel, J. K.
    Seid, A.
    Mansukhani, A.
    Thompson, O. M.
    Wu, G. W.
    Laks, H.
    Kobashigawa, J. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S100 - S101
  • [44] Microvascular dysfunction preceeds epicardial coronary stenosis in heart transplant patients with cardiac allograft vasculopathy
    Osto, E.
    Tona, F.
    Gambino, A.
    Maddalozzo, A.
    Caforio, A. L. P.
    Montisci, R.
    Ramondo, A.
    Gerosa, G.
    Iliceto, S.
    EUROPEAN HEART JOURNAL, 2009, 30 : 157 - 157
  • [45] Sirolimus Therapy and Risk of Late Cellular Rejection in Heart Transplant Patients with Cardiac Allograft Vasculopathy
    Scatola, A.
    Nnani, D.
    Sun, E.
    Alvarez, C.
    Rivas-Lasarte, M.
    Saeed, O.
    Patel, S.
    Sims, D.
    Shin, J.
    Goldstein, D.
    Jorde, U.
    Vukelic, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S278 - S279
  • [46] Statin therapy in cardiac allograft vasculopathy progression in heart transplant patients: Does potency matter?
    Sieg, Adam
    Weeks, Phillip
    Krustchinsky, Lori
    Rajapreyar, Indranee
    TRANSPLANTATION REVIEWS, 2016, 30 (03) : 178 - 186
  • [47] PREDICTORS OF ACUTE CELLULAR REJECTION AND ITS ASSOCIATION WITH CARDIAC ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT PATIENTS
    Khalife, W. I.
    Vivo, R. P.
    Garikipati, S.
    Nalabothu, P.
    Johnson, S.
    Kislingbury, K.
    Sharif, R.
    Charif, A.
    CARDIOLOGY, 2013, 125 : 115 - 115
  • [48] Coronary computed tomography in heart transplant patients: detection of significant stenosis and cardiac allograft vasculopathy, image quality, and radiation dose
    Gunther, Anne
    Aaberge, Lars
    Abildgaard, Andreas
    Ragnarsson, Asgrimur
    Edvardsen, Thor
    Jakobsen, Jarl
    Andersen, Rune
    ACTA RADIOLOGICA, 2018, 59 (09) : 1066 - 1073
  • [49] Myocardial flow reserve using 13N ammonia PET for detection of cardiac allograft vasculopathy in heart transplant patients
    Kikuchi, N.
    Yamamoto, E.
    Nagao, M.
    Momose, M.
    Hattori, H.
    Suzuki, A.
    Shiga, T.
    Niinami, H.
    Hagiwara, N.
    Nunoda, S.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1981 - 1981
  • [50] Value of QT dispersion analysis for noninvasive detection of cardiac allograft rejection
    Regueiro-Abel, M
    Crespo-Leiro, MG
    Muñiz, J
    Gonzalez-Juanatey, JR
    Paniagua, MJ
    Rodriguez, JA
    Vazquez-Rodriguez, JM
    Juffe, A
    Castro-Beiras, A
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 168 - 170
12345